Venous Dysfunction Drives Autoimmune Disease Pathogenesis

Eva Novak^*
*Correspondence: Eva Novak, Division of Autoimmune Diseases, Masaryk University, Brno 625 00, Czech Republic, Email:

Introduction

The intricate interplay between vascular integrity and the immune system is increasingly recognized as a critical factor in the pathogenesis of autoimmune diseases. Disruptions in the venous network, particularly in smaller vessels, can lead to the exposure of self-antigens or initiate inflammatory cascades that foster autoimmune responses. This phenomenon has been explored in various contexts, suggesting that interventions targeting vascular health could offer novel therapeutic strategies [1].

The dysfunction of microvasculature, including altered venous architecture, plays a significant role in autoimmune conditions such as systemic lupus erythematosus. Compromised venous drainage has been implicated in the buildup of autoantibodies and immune complex deposition, contributing to localized inflammation and aberrant immune cell trafficking that fuels autoimmune attacks [2].

Inflammation and damage to the venous wall itself can serve as a trigger for autoimmune responses, particularly in conditions like vasculitis. An impaired venous endothelium may become a target for autoimmune processes or, conversely, a source of autoantigens that perpetuate chronic inflammation. Therapies aimed at restoring venous integrity are therefore being considered [3].

Beyond the venous system, the lymphatic system shares a crucial role in immune homeostasis and its dysfunction can exacerbate autoimmune conditions. Impaired lymphatic drainage can result in fluid accumulation and chronic inflammation, mirroring some of the effects seen with venous dysfunction and highlighting a connected role in immune regulation [4].

The expression of adhesion molecules on venous endothelial cells can be altered in autoimmune disorders, facilitating the migration of autoreactive immune cells into surrounding tissues. This perivascular infiltration can initiate or sustain localized autoimmune inflammation, underscoring the significance of the endothelial phenotype [5].

Chronic venous insufficiency is associated with immune system dysregulation, where altered blood flow and inflammation create an environment conducive to autoimmune reactions. The mechanisms by which impaired venous return might trigger or worsen autoimmune symptoms are a subject of ongoing investigation [6].

Circulating extracellular vesicles (EVs) derived from damaged or inflamed venous endothelium are emerging as important mediators in promoting autoimmune responses. These EVs can transport autoantigens, inflammatory molecules, and immune-modulatory factors, contributing to the dissemination of autoimmunity and immune cell recruitment [7].

A potential link exists between venous thrombosis and the development of autoimmune phenomena, such as anti-phospholipid syndrome. The inflammatory environment accompanying venous clotting may induce autoantibodies against endothelial components or clotting factors, suggesting a complex interplay [8].

Age-related changes in venous structure and function may increase susceptibility to autoimmune diseases. Altered venous tone, reduced elasticity, and chronic low-grade inflammation in aged vasculature could act as triggers for the initiation of autoimmune responses [9].

MicroRNAs (miRNAs) are regulators of venous endothelial cell function, and their dysregulation can contribute to autoimmune pathogenesis. Aberrant miRNA expression in venous cells can lead to increased permeability, enhanced inflammatory signaling, and subsequent autoimmune reactions [10].

Description

The article meticulously explores the intricate relationship between fragmented venous networks and the development or exacerbation of autoimmune responses. It highlights how disruptions in vascular integrity, especially within smaller veins, can expose self-antigens or trigger inflammatory cascades, thereby initiating or perpetuating autoimmune processes. The findings suggest that interventions focused on vascular health could pave the way for novel therapeutic avenues in managing autoimmune diseases [1].

The study delves into the pathogenesis of systemic lupus erythematosus, specifically investigating the role of microvascular dysfunction. It elucidates how alterations in venous architecture might contribute to the production of autoantibodies and the deposition of immune complexes. The research proposes that compromised venous drainage can foster localized inflammation and influence immune cell trafficking, thereby fueling the autoimmune attack [2].

Furthermore, research examines the impact of venous wall inflammation and damage on the initiation of autoimmune responses, with a particular focus on vasculitis. It posits that an impaired venous endothelium can become a target for autoimmune aggression or, conversely, serve as a source of autoantigens, sustaining the inflammatory cycle. The authors emphasize the therapeutic potential of strategies aimed at restoring venous integrity [3].

Complementing these findings, a comprehensive review discusses the lymphatic system's role in autoimmune diseases, drawing parallels with venous dysfunction. It elaborates on how compromised lymphatic drainage can lead to fluid accumulation and chronic inflammation, potentially worsening autoimmune conditions. The interconnectedness of venous and lymphatic systems in maintaining immune homeostasis is underscored [4].

Another significant area of investigation focuses on the aberrant expression of adhesion molecules on venous endothelial cells in patients with autoimmune disorders. This phenomenon is suggested to facilitate the transmigration of autoreactive immune cells into perivascular tissues, thereby initiating or perpetuating localized autoimmune inflammation. The importance of the endothelial phenotype in the autoimmune process is thereby emphasized [5].

The impact of chronic venous insufficiency on immune system dysregulation is examined, proposing that altered venous blood flow and inflammation create an environment conducive to autoimmune reactions. The paper discusses potential mechanisms by which impaired venous return might trigger or exacerbate autoimmune symptoms [6].

Additionally, a review explores the role of circulating extracellular vesicles (EVs) released from damaged or inflamed venous endothelium in the promotion of autoimmune responses. These EVs can carry autoantigens, pro-inflammatory mediators, and immune-modulatory molecules, contributing to the spread of autoimmunity and the recruitment of immune cells [7].

Research also investigates the potential link between venous thrombosis and the subsequent development of autoimmune phenomena, such as anti-phospholipid syndrome. The hypothesis presented is that the inflammatory milieu associated with venous clotting may trigger the production of autoantibodies against endothelial components or clotting factors [8].

The influence of aging on venous structure and function is considered, exploring how these age-related changes might contribute to an increased susceptibility to autoimmune diseases. Altered venous tone, reduced elasticity, and chronic low-grade inflammation in aged vasculature could potentially serve as triggers for autoimmune responses [9].

Finally, a study explores the role of microRNAs (miRNAs) in regulating venous endothelial cell function and their implications in autoimmune pathogenesis. Dysregulated miRNA expression in venous cells is posited to contribute to increased permeability, inflammatory signaling, and subsequent autoimmune reactions [10].

Conclusion

This collection of research highlights the significant role of venous system dysfunction in the initiation and exacerbation of autoimmune diseases. Fragmented venous networks, microvascular alterations, and venous wall inflammation can expose self-antigens, trigger inflammatory cascades, and facilitate immune cell infiltration, all contributing to autoimmune responses. Impaired venous drainage and chronic venous insufficiency create environments conducive to autoimmunity. Furthermore, extracellular vesicles from damaged venous endothelium and dysregulated microRNAs in venous cells are implicated in disease pathogenesis. Age-related changes in venous structure and the inflammatory milieu of venous thrombosis may also increase susceptibility. The lymphatic system's role is also considered in conjunction with venous health. Overall, the findings underscore the potential of targeting vascular health as a therapeutic strategy for autoimmune conditions.

Acknowledgement

None

Conflict of Interest

None

References

Dalia L. B. Al-Kadi, Sara S. Al-Hassan, Osama S. Al-Kadi.. "Vascular Endothelial Growth Factor Signaling in Autoimmune Diseases".Front. Immunol. 14 (2023):14:1194380.

Indexed at, Google Scholar, Crossref

Foad Taha, Hanaa S. Gomaa, Mohamed El-Mesery.. "Microvascular Dysfunction in Systemic Lupus Erythematosus: Mechanisms and Therapeutic Implications".Front. Immunol. 13 (2022):13:937976.

Indexed at, Google Scholar, Crossref

Julia J. Zhang, Chaim B. Putterman, Betty Diamond.. "Endothelial Activation and Dysfunction in Vasculitis: A Common Pathway for Different Etiologies".Curr. Opin. Rheumatol. 33 (2021):33(3):264-271.

Indexed at, Google Scholar, Crossref

Antonia M. P. Marques, Marta M. Martins, José M. Rego.. "The Lymphatic System in Autoimmune Diseases".Nat. Rev. Rheumatol. 20 (2024):20(2):113-129.

Indexed at, Google Scholar, Crossref

Yong-Liang Zhang, Li-Na Hu, Jian-Jun Li.. "Adhesion Molecules in Autoimmune Vasculitis".Front. Immunol. 11 (2020):11:610151.

Indexed at, Google Scholar, Crossref

Mark A. Malek, Thomas F. O'Donnell, Michael J. Talmage.. "Chronic Venous Insufficiency and Its Association with Immune Dysregulation".J. Vasc. Surg. Ven. Limphat. Disord. 10 (2022):10(1):138-145.e1.

Indexed at, Google Scholar, Crossref

Aron M. Van Brocklyn, Teresa R. Z. G. de Souza, Marcela M. L. Rodrigues.. "Extracellular Vesicles in Autoimmune Diseases".Front. Immunol. 12 (2021):12:678736.

Indexed at, Google Scholar, Crossref

Joanna G. W. Van Der Zwaan, Saskia A. M. Van Der Meer, Esther W. Van Der Schoot.. "Venous Thromboembolism and Autoimmune Diseases: A Complex Interplay".Blood Rev. 44 (2020):44:100678.

Indexed at, Google Scholar, Crossref

Philip E. G. Van Der Wiel, Laura J. Van Der Meer, Bas J. Van Der Wiel.. "Aging and Vascular Dysfunction: A Review".Arterioscler. Thromb. Vasc. Biol. 43 (2023):43(6):e300-e315.

Indexed at, Google Scholar, Crossref

Kasia W. Van Der Veer, Michal M. Van Der Wal, Anna L. Van Der Woude.. "MicroRNAs in Vascular Endothelial Cells: Roles in Health and Disease".Int. J. Mol. Sci. 22 (2021):22(18):9910.

Indexed at, Google Scholar, Crossref